These results indicate that these active ingredients of CSF have high binding affinities with NF‐κB p65 and NLRP3, which may inhibit the activation of inflammation signaling pathways and alleviate the development and progression of ALI. This evidence concerns the gene NFKB1 and acute respiratory distress syndrome.